These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 26386360

  • 1. Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain.
    Maschauer S, Haller A, Riss PJ, Kuwert T, Prante O, Cumming P.
    J Neurochem; 2015 Dec; 135(5):908-17. PubMed ID: 26386360
    [Abstract] [Full Text] [Related]

  • 2. Detection of monoamine oxidase a in brain of living rats with [18F]fluoroethyl-harmol PET.
    Cumming P, Skaper D, Kuwert T, Maschauer S, Prante O.
    Synapse; 2015 Jan; 69(1):57-9. PubMed ID: 25229748
    [Abstract] [Full Text] [Related]

  • 3. Selective binding to monoamine oxidase A: in vitro and in vivo evaluation of (18)F-labeled β-carboline derivatives.
    Schieferstein H, Piel M, Beyerlein F, Lüddens H, Bausbacher N, Buchholz HG, Ross TL, Rösch F.
    Bioorg Med Chem; 2015 Feb 01; 23(3):612-23. PubMed ID: 25541203
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain.
    Ginovart N, Meyer JH, Boovariwala A, Hussey D, Rabiner EA, Houle S, Wilson AA.
    J Cereb Blood Flow Metab; 2006 Mar 01; 26(3):330-44. PubMed ID: 16079787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).
    Nag S, Lehmann L, Kettschau G, Heinrich T, Thiele A, Varrone A, Gulyas B, Halldin C.
    Bioorg Med Chem; 2012 May 01; 20(9):3065-71. PubMed ID: 22436387
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
    May T, Greube A, Strauss S, Heineke D, Lehmann J, Rommelspacher H.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar 01; 349(3):308-17. PubMed ID: 8208308
    [Abstract] [Full Text] [Related]

  • 9. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB, Olsen AK, Pedersen K, Cumming P.
    Synapse; 2006 Jun 01; 59(7):427-34. PubMed ID: 16485265
    [Abstract] [Full Text] [Related]

  • 10. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A.
    Alzheimers Res Ther; 2017 Dec 11; 9(1):96. PubMed ID: 29229003
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity.
    Nag S, Kettschau G, Heinrich T, Varrone A, Lehmann L, Gulyas B, Thiele A, Keller É, Halldin C.
    Bioorg Med Chem; 2013 Jan 01; 21(1):186-95. PubMed ID: 23211968
    [Abstract] [Full Text] [Related]

  • 12. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, García-Sevilla JA.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):234-42. PubMed ID: 16061219
    [Abstract] [Full Text] [Related]

  • 13. 11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies.
    Bergström M, Westerberg G, Långström B.
    Nucl Med Biol; 1997 May 22; 24(4):287-93. PubMed ID: 9257326
    [Abstract] [Full Text] [Related]

  • 14. [3H]harman binding experiments. I: A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat.
    May T, Rommelspacher H, Pawlik M.
    J Neurochem; 1991 Feb 22; 56(2):490-9. PubMed ID: 1988552
    [Abstract] [Full Text] [Related]

  • 15. Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).
    Nag S, Lehmann L, Kettschau G, Toth M, Heinrich T, Thiele A, Varrone A, Halldin C.
    Bioorg Med Chem; 2013 Nov 01; 21(21):6634-41. PubMed ID: 24012376
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of monoamine oxidase A and B type enzyme occupancy using non-radiolabelled tracers in rat brain.
    Thentu JB, Bhyrapuneni G, Padala NP, Chunduru P, Pantangi HR, Nirogi R.
    Neurochem Int; 2021 May 01; 145():105006. PubMed ID: 33636211
    [Abstract] [Full Text] [Related]

  • 17. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.
    Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH.
    Int J Neuropsychopharmacol; 2015 Aug 27; 19(1):. PubMed ID: 26316187
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V, van Wieringen JP, Janssen HM, Fransen PM, Dierckx RA, Michel MC, Booij J, Elsinga PH.
    J Nucl Med; 2015 Jan 27; 56(1):133-9. PubMed ID: 25476538
    [Abstract] [Full Text] [Related]

  • 19. Acute inhibition of cardiac monoamine oxidase A after tobacco smoke inhalation: validation study of [11C]befloxatone in rats followed by a positron emission tomography application in baboons.
    Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A.
    J Pharmacol Exp Ther; 2005 Jul 27; 314(1):431-6. PubMed ID: 15833896
    [Abstract] [Full Text] [Related]

  • 20. 18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging.
    Harada R, Hayakawa Y, Ezura M, Lerdsirisuk P, Du Y, Ishikawa Y, Iwata R, Shidahara M, Ishiki A, Kikuchi A, Arai H, Kudo Y, Yanai K, Furumoto S, Okamura N.
    J Nucl Med; 2021 Feb 27; 62(2):253-258. PubMed ID: 32646880
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.